Barclays raised the firm’s price target on RXO Inc. (RXO) to $20 from $17 and keeps an Overweight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO:
- RXO Inc. price target raised to $22 from $15 at Wells Fargo
- Ken Hoexter Lifts RXO Price Target to $25 on AI-Driven Gains but Maintains Hold Amid Balanced Risk-Reward
- RXO Earnings Call Signals Early Supply-Led Recovery
- RXO Inc. downgraded to Equal Weight from Overweight at Morgan Stanley
- RXO Inc. reports Q1 adjusted EPS (9c), consensus (9c)